Edwards Lifesciences to Host Earnings Conference Call on July 25, 2013
(firmenpresse) - IRVINE, CA -- (Marketwired) -- 07/11/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, plans to announce its operating results for the quarter ended June 30, 2013 after the market closes on Thursday, July 25, 2013 and will host a conference call at 5:00 p.m. ET that day to discuss its results.
To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using conference number 417089. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at . An archived replay can also be accessed via mobile devices by downloading Edwards' IR App for or .
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at .
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.
Sarah Huoh
949-250-5070
David K. Erickson
949-250-6826
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.07.2013 - 11:04 Uhr
Sprache: Deutsch
News-ID 1244706
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
IRVINE, CA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 110 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Edwards Lifesciences to Host Earnings Conference Call on July 25, 2013
"
steht unter der journalistisch-redaktionellen Verantwortung von
Edwards Lifesciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
